$6.20
-0.03-0.48%
At Close: -
$6.18
-0.02-0.32%
After Hours: 5:03 PM EDT
15 minutes delayed
Comments
Loading...
Black Diamond Therapeutic
BDTXNASDAQ
Black Diamond Therapeutic (NASDAQ:BDTX) Stock, Insider Trading Activity
Black Diamond Therapeutic: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Black Diamond Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Black Diamond Therapeutics Inc
Institutional Shares Held
28.184M
Institutional Percentage Held
50.1%
| Oct 19, 2023 | GROWTH BIOTECH VBB BIOTECH AG | — | 400.00K | $2.34 | $934.08K | BUY | 4.93% | 8.52M | Oct 17 | View |
| Jul 07, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund LPPeter KolchinskyRajeev Shah | DIRECTOR | 935.85K | $5.00 | $4.68M | BUY | 36.13% | 3.53M | Jul 05 | View |
| Jul 06, 2023 | Ali Behbahani | DIRECTOR | 1.00M | $5.00 | $5.00M | BUY | 28.66% | 4.49M | Jul 05 | View |
| Jul 03, 2023 | GROWTH BIOTECH VBB BIOTECH AG | — | 1.00M | $5.00 | $5.00M | BUY | 14.05% | 8.12M | Jun 30 | View |
| Jun 29, 2023 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 1.74M | $5.49 | $9.56M | BUY | 32.36% | 7.12M | Jun 27 | View |
| Jun 28, 2023 | David Epstein | SEE REMARKS | -25.00K | $6.70 | -$167.50K | SELL | -3.51% | 688.00K | Jun 27 | View |
| Dec 23, 2022 | Fang Ni | SEE REMARKS | 56.36K | $1.28 | $72.37K | BUY | 81.65% | 125.39K | Dec 21 - Dec 22 | View |
| Nov 02, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 99.80K | $2.25 | $224.91K | BUY | 1.89% | 5.38M | Oct 31 | View |
| Oct 31, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 364.65K | $2.02 | $736.19K | BUY | 7.42% | 5.28M | Oct 27 - Oct 28 | View |
| Oct 25, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 87.85K | $1.51 | $132.75K | BUY | 1.82% | 4.91M | Oct 21 | View |
| Oct 21, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 131.42K | $1.36 | $179.12K | BUY | 2.80% | 4.83M | Oct 19 - Oct 20 | View |
| Jun 30, 2022 | Fang Ni | SEE REMARKS | 25.00K | $2.44 | $61.02K | BUY | 56.78% | 69.03K | Jun 29 | View |
| Apr 29, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 405.71K | $2.61 | $1.06M | BUY | 9.46% | 4.69M | Apr 27 - Apr 28 | View |
| Apr 20, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 300.00K | $3.27 | $980.58K | BUY | 7.52% | 4.29M | Apr 18 - Apr 19 | View |
| Apr 14, 2022 | GROWTH BIOTECH VBB BIOTECH AG | 10% OWNER | 252.56K | $3.48 | $879.82K | BUY | 6.76% | 3.99M | Apr 12 - Apr 13 | View |
| May 13, 2021 | Brent Hatzis-Schoch | SEE REMARKS | 0.00 | $15.31 | -$98.76K | SELL-OPTIONS | 0.00% | 8.40K | May 12 | View |
| May 05, 2021 | Christopher Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.75 | -$39.45K | SELL-OPTIONS | 0.00% | 3.20K | May 03 | View |
| Apr 13, 2021 | Brent Hatzis-Schoch | SEE REMARKS | 0.00 | $14.10 | -$88.90K | SELL-OPTIONS | 0.00% | 8.40K | Apr 12 | View |
| Apr 07, 2021 | Christopher Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.20 | -$36.70K | SELL-OPTIONS | 0.00% | 3.20K | Apr 05 | View |
| Mar 16, 2021 | Brent Hatzis-Schoch | SEE REMARKS | 0.00 | $14.78 | -$94.44K | SELL-OPTIONS | 0.00% | 8.40K | Mar 12 | View |
| Mar 04, 2021 | Christopher Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.48 | -$38.11K | SELL-OPTIONS | 0.00% | 3.20K | Mar 03 | View |
| Feb 12, 2021 | Brent Hatzis-Schoch | SEE REMARKS | 0.00 | $15.21 | -$97.98K | SELL-OPTIONS | 0.00% | 8.40K | Feb 12 | View |
| Feb 04, 2021 | Christopher Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.11 | -$36.23K | SELL-OPTIONS | 0.00% | 3.20K | Feb 03 | View |
| Jan 14, 2021 | Brent Hatzis-Schoch | SEE REMARKS | 0.00 | $21.10 | -$299.54K | SELL-OPTIONS | 0.00% | 8.40K | Jan 12 | View |
| Jan 11, 2021 | Thomas Leggett | CHIEF FINANCIAL OFFICER | 0.00 | $22.40 | -$69.24K | SELL-OPTIONS | 0.00% | 0.00 | Jan 08 | View |
| Jan 06, 2021 | Christopher Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $21.13 | -$51.37K | SELL-OPTIONS | 0.00% | 3.20K | Jan 04 | View |
| Jan 06, 2021 | David Epstein | SEE REMARKS | -9.00K | $18.77 | -$354.24K | SELL | -1.25% | 713.00K | Jan 04 | View |
| Dec 16, 2020 | Brent Hatzis-Schoch | — | 0.00 | $19.07 | -$129.47K | OPTION EXERCISE | 0.00% | 3.00K | Dec 14 | View |
| Dec 10, 2020 | Thomas Leggett | — | 0.00 | $22.32 | -$68.75K | OPTION EXERCISE | 0.00% | 0.00 | Dec 08 | View |
| Dec 04, 2020 | Christopher Roberts | — | 0.00 | $21.64 | -$53.91K | OPTION EXERCISE | 0.00% | 0.00 | Dec 03 | View |
| Dec 03, 2020 | David Epstein | — | -9.00K | $19.57 | -$373.31K | OPTION EXERCISE | -1.24% | 719.50K | Dec 01 | View |
| Dec 01, 2020 | Bradley J. Bolzon, PhD. | — | -433.30K | $33.15 | -$344.51K | ACQUISITION OR DISPOSITION | -51.82% | 402.78K | Nov 27 - Nov 30 | View |
| Dec 01, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -435.57K | $33.15 | -$344.51K | ACQUISITION OR DISPOSITION | -53.35% | 380.94K | Nov 27 - Nov 30 | View |
| Nov 23, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -130.02K | $33.01 | -$4.29M | SELL | -2.42% | 5.25M | Nov 19 | View |
| Nov 23, 2020 | Bradley J. Bolzon, PhD | — | -130.02K | $33.01 | -$4.29M | SELL | -2.62% | 4.83M | Nov 19 | View |
| Nov 19, 2020 | Bradley J. Bolzon, PhD | — | -4.73K | $33.05 | -$156.35K | SELL | -0.10% | 4.95M | Nov 17 - Nov 18 | View |
| Nov 19, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -4.73K | $33.05 | -$156.35K | SELL | -0.09% | 5.36M | Nov 17 - Nov 18 | View |
| Nov 17, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -4.70K | $33.74 | -$158.59K | SELL | -0.09% | 5.36M | Nov 13 - Nov 16 | View |
| Nov 17, 2020 | Bradley J. Bolzon, PhD | — | -4.70K | $33.74 | -$158.59K | SELL | -0.09% | 4.95M | Nov 13 - Nov 16 | View |
| Nov 13, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -965.60K | $34.15 | -$532.64K | ACQUISITION OR DISPOSITION | -16.35% | 4.94M | Nov 11 - Nov 12 | View |
| Nov 13, 2020 | Bradley J. Bolzon, PhD. | — | -960.14K | $34.15 | -$532.64K | ACQUISITION OR DISPOSITION | -16.27% | 4.94M | Nov 11 - Nov 12 | View |
| Nov 13, 2020 | Christopher Roberts | — | 0.00 | $22.88 | -$120.20K | OPTION EXERCISE | 0.00% | 0.00 | Nov 11 | View |
| Nov 13, 2020 | Brent Hatzis-Schoch | — | 0.00 | $18.59 | -$125.56K | OPTION EXERCISE | 0.00% | 3.00K | Nov 12 | View |
| Nov 12, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -39.58K | $34.11 | -$1.35M | SELL | -0.64% | 6.13M | Nov 10 - Nov 11 | View |
| Nov 12, 2020 | Bradley J. Bolzon, PhD. | — | -39.58K | $34.11 | -$1.35M | SELL | -0.69% | 5.66M | Nov 10 - Nov 11 | View |
| Nov 12, 2020 | Thomas Leggett | — | 0.00 | $21.91 | -$66.31K | OPTION EXERCISE | 0.00% | 0.00 | Nov 09 | View |
| Nov 10, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -9.40K | $33.08 | -$310.95K | SELL | -0.15% | 6.17M | Nov 06 - Nov 09 | View |
| Nov 10, 2020 | Bradley J. Bolzon, PhD. | — | -9.40K | $33.08 | -$310.95K | SELL | -0.16% | 5.69M | Nov 06 - Nov 09 | View |
| Nov 06, 2020 | Bradley J. Bolzon, PhD. | — | -11.35K | $33.14 | -$376.13K | SELL | -0.20% | 5.70M | Nov 04 - Nov 05 | View |
| Nov 06, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -11.35K | $33.14 | -$376.13K | SELL | -0.18% | 6.18M | Nov 04 - Nov 05 | View |
| Nov 04, 2020 | Christopher Roberts | — | 0.00 | $21.40 | -$52.72K | OPTION EXERCISE | 0.00% | 0.00 | Nov 03 | View |
| Nov 03, 2020 | David Epstein | — | -9.00K | $18.78 | -$354.40K | OPTION EXERCISE | -1.22% | 728.50K | Nov 02 | View |
| Oct 28, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -8.90K | $33.28 | -$296.29K | SELL | -0.14% | 6.19M | Oct 26 - Oct 27 | View |
| Oct 28, 2020 | Bradley J. Bolzon, PhD. | — | -8.90K | $33.28 | -$296.29K | SELL | -0.16% | 5.71M | Oct 26 - Oct 27 | View |
| Oct 20, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -15.75K | $33.44 | -$526.53K | SELL | -0.25% | 6.19M | Oct 15 - Oct 19 | View |
| Oct 20, 2020 | Bradley J. Bolzon, PhD. | — | -15.75K | $33.44 | -$526.53K | SELL | -0.27% | 5.72M | Oct 15 - Oct 19 | View |
| Oct 15, 2020 | Bradley J. Bolzon, PhD. | — | -17.24K | $33.30 | -$574.02K | SELL | -0.30% | 5.73M | Oct 13 - Oct 14 | View |
| Oct 15, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -17.24K | $33.30 | -$574.02K | SELL | -0.28% | 6.21M | Oct 13 - Oct 14 | View |
| Oct 14, 2020 | Brent Hatzis-Schoch | — | 0.00 | $17.95 | -$120.28K | OPTION EXERCISE | 0.00% | 3.00K | Oct 12 | View |
| Oct 13, 2020 | Bradley J. Bolzon, PhD. | — | -22.63K | $33.50 | -$757.92K | SELL | -0.39% | 5.75M | Oct 08 - Oct 12 | View |
| Oct 13, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -22.63K | $33.50 | -$757.92K | SELL | -0.36% | 6.22M | Oct 08 - Oct 12 | View |
| Oct 09, 2020 | Thomas Leggett | — | 0.00 | $22.19 | -$68.00K | OPTION EXERCISE | 0.00% | 0.00 | Oct 08 | View |
| Oct 08, 2020 | Bradley J. Bolzon, PhD. | — | -334.06K | $33.44 | -$1.54M | ACQUISITION OR DISPOSITION | -97.04% | 10.18K | Oct 06 - Oct 07 | View |
| Oct 08, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -335.53K | $33.44 | -$1.54M | ACQUISITION OR DISPOSITION | -100.00% | 0.00 | Oct 06 - Oct 07 | View |
| Oct 07, 2020 | Christopher Roberts | — | 0.00 | $21.07 | -$51.04K | OPTION EXERCISE | 0.00% | 0.00 | Oct 05 | View |
| Oct 02, 2020 | David Epstein | — | -9.00K | $18.38 | -$344.70K | OPTION EXERCISE | -1.21% | 737.50K | Oct 01 | View |
| Oct 01, 2020 | ALEXANDER ROBERT INGRAM | — | 5.00K | $30.46 | $152.28K | PURCHASE | ∞ | 5.00K | Sep 30 | View |
| Sep 16, 2020 | Brent Hatzis-Schoch | — | 0.00 | $17.12 | -$113.53K | OPTION EXERCISE | 0.00% | 3.00K | Sep 14 | View |
| Sep 16, 2020 | Thomas Leggett | — | 0.00 | $20.93 | -$60.42K | OPTION EXERCISE | 0.00% | 0.00 | Sep 14 | View |
| Sep 04, 2020 | Christopher Roberts | — | 0.00 | $20.23 | -$46.84K | OPTION EXERCISE | 0.00% | 0.00 | Sep 03 | View |
| Aug 12, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | -13.79K | $33.06 | -$455.99K | SELL | -0.19% | 7.40M | Aug 10 - Aug 11 | View |
| Aug 12, 2020 | Bradley J. Bolzon, PhD. | — | -13.79K | $33.06 | -$455.99K | SELL | -0.20% | 6.80M | Aug 10 - Aug 11 | View |
| Feb 05, 2020 | Versant Venture Capital VI LPVersant Voyageurs I Parallel LPVersant Voyageurs I LPVersant Vantage I LP | — | 10.55M | $19.00 | $17.00M | DERIVATIVE CONVERSION | ∞ | 1.21M | Feb 03 | View |
| Feb 05, 2020 | PhD Bradley Bolzon | — | 10.55M | $19.00 | $17.00M | DERIVATIVE CONVERSION | ∞ | 1.21M | Feb 03 | View |
| Feb 05, 2020 | Rajeev Shah | — | 2.59M | $19.00 | $19.00M | DERIVATIVE CONVERSION | ∞ | 353.81K | Feb 03 | View |
| Feb 05, 2020 | Brent Hatzis-Schoch | — | 3.00K | $19.00 | $57.00K | PURCHASE | ∞ | 3.00K | Feb 03 | View |
| Feb 05, 2020 | Ali Behbahani | — | 3.45M | $19.00 | $15.20M | DERIVATIVE CONVERSION | ∞ | 3.45M | Feb 03 | View |
| Feb 03, 2020 | James FlynnDeerfield Mgmt LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDEERFIELD PARTNERS LP | — | 778.79K | $19.00 | $7.60M | DERIVATIVE CONVERSION | ∞ | 778.79K | Feb 03 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.